Skip to main content

Zyomyx Sells Protein Biochip System to National Eye Institute

NEW YORK, Nov. 4 (GenomeWeb News) - Zyomyx said today that the National Eye Institute of the National Institutes of Health would use the Zyomyx Protein Profiling Biochip System for its research into ocular disease.

NEI will use the system to study inflammatory, autoimmune, and other diseases of the eye.

Further details of the agreement were not provided.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.